BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | NDAQ

Overview

Corporate Details

ISIN(s):: US09061G1013
LEI:
Country:: United States of America
Address:: 105 DIGITAL DRIVE, 94949 NOVATO
Website:: https://www.biomarin.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Dermapharm Holding SE Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.	Germany	DMP
Dermata Therapeutics, Inc. Develops OTC skin treatments using a unique delivery technology from freshwater sponges.	United States of America	DRMA
Design Therapeutics, Inc. Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.	United States of America	DSGN
Deutsche Biotech Innovativ AG Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.	Germany	DBI
DEVA HOLDİNG A.Ş. Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.	Spain	DEVA
Devyser Diagnostics Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.	Sweden	DVYSR
DiaMedica Therapeutics Inc. Developing a novel protein therapy for acute ischemic stroke and preeclampsia.	United States of America	DMAC
Diamyd Medical AB (publ) Developing precision immunotherapies to preserve insulin in autoimmune diabetes.	Sweden	DMYD
Dianthus Therapeutics, Inc. /DE/ Developing selective antibody therapies for severe autoimmune diseases.	United States of America	DNTH
Diasorin Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.	Italy	DIA